SRXH

SRx Health Solutions Inc. SRXH

SRXH
SRx Health Solutions Inc. TXMD
TherapeuticsMD, Inc. FLGC
Flora Growth Corp. IMRN
Immuron Limited CHEK
Check-Cap Ltd. SINT
Sintx Technologies, Inc. ACXP
Acurx Pharmaceuticals, Inc. EVGN
Evogene Ltd. DWTX
Dogwood Therapeutics, Inc. CODX
Co-Diagnostics, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode SRXH TXMD FLGC IMRN CHEK SINT ACXP EVGN DWTX CODX
6M -82.93 % 13.91 % -48.41 % 22.91 % 101.27 % 40.70 % -18.42 % 14.41 % 8.86 % 260.00 %
YTD -83.50 % -16.56 % -73.28 % 23.60 % 37.07 % -0.55 % -60.71 % -34.54 % 139.84 % 74.37 %
1Y -83.50 % -16.56 % -84.89 % 13.99 % 34.75 % 11.35 % -82.54 % -46.64 % 23.61 % 0.80 %
3Y -83.50 % -77.98 % -97.46 % 14.58 % -67.01 % -99.82 % -89.56 % -84.09 % -15.57 % -60.38 %
5Y -83.50 % -98.10 % -99.69 % -69.49 % -74.68 % -99.99 % -95.82 % -95.88 % -98.56 % -91.15 %
10Y -83.50 % -99.56 % -99.69 % -73.68 % -99.77 % -100.00 % -95.82 % -98.35 % -98.56 % -78.31 %
From the beginning -83.50 % -99.97 % -99.69 % -73.68 % -99.89 % -100.00 % -95.82 % -90.59 % -98.56 % -78.31 %

Dividend